Drug Repurposing Patent Applications July–September 2025

    January 2025 in “ Drug repurposing ”
    Hermann A. M. Mucke
    Studysummary This study reviewed 16 notable drug repurposing patent applications from 2025, highlighting potential new uses such as guanfacine for autonomic dysfunction and disulfiram for subarachnoid hemorrhage survival, though many disclosures lack peer-reviewed studies and no patents are granted.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on drugrepocentral.scienceopen.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Low-Dose Metformin and Profibrotic Signature in Central Centrifugal Cicatricial Alopecia JAMA Dermatology · 2024
    2. Hair Regrowth in Two Patients with Recalcitrant Central Centrifugal Cicatricial Alopecia After Use of Topical Metformin JAAD Case Reports · 2020
    3. Altered Polyamine Profiling in the Hair of Patients with Androgenic Alopecia and Alopecia Areata Journal of Dermatology · 2019
    4. Alopecia Areata: A Tissue-Specific Autoimmune Disease of the Hair Follicle Autoimmunity Reviews · 2005